Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.
Cahan B, Leong L, Wagman L, Yamauchi D, Shibata S, Wilzcynski S, Williams LE, Yazaki P, Colcher D, Frankel P, Wu A, Raubitschek A, Shively J, Wong JYC. Cahan B, et al. Among authors: frankel p. Cancer Biother Radiopharm. 2017 Sep;32(7):258-265. doi: 10.1089/cbr.2017.2223. Cancer Biother Radiopharm. 2017. PMID: 28910150 Free PMC article. Clinical Trial.
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.
Akhavan D, Yazaki P, Yamauchi D, Simpson J, Frankel PH, Bading J, Colcher D, Poku K, Chen YJ, Lim D, Cristea M, Wu A, Shively J, Wong JYC. Akhavan D, et al. Among authors: frankel ph. Cancer Biother Radiopharm. 2020 Feb;35(1):10-15. doi: 10.1089/cbr.2019.2992. Epub 2020 Jan 7. Cancer Biother Radiopharm. 2020. PMID: 31910346 Free PMC article. Clinical Trial.
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.
Wong JYC, Yamauchi DM, Adhikarla V, Simpson J, Frankel PH, Fong Y, Melstrom KA, Chen YJ, Salehian BD, Woo Y, Dandapani SV, Colcher DM, Poku EK, Yazaki PJ, Wu AM, Shively JE. Wong JYC, et al. Cancer Biother Radiopharm. 2023 Feb;38(1):26-37. doi: 10.1089/cbr.2022.0028. Epub 2022 Sep 26. Cancer Biother Radiopharm. 2023. PMID: 36154291
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Hernandez MC, Yazaki P, Mortimer JE, Yamauchi D, Poku E, Park J, Frankel P, Kim J, Colcher DM, Wong J, Fong Y, Shively J, Woo Y. Hernandez MC, et al. Among authors: frankel p. Nucl Med Commun. 2023 Dec 1;44(12):1151-1155. doi: 10.1097/MNM.0000000000001761. Epub 2023 Oct 30. Nucl Med Commun. 2023. PMID: 37901917
Using a single parameter to describe time-activity curves.
Kwok CS, Frankel PH, Lopatin G, Williams LE. Kwok CS, et al. Cancer Biother Radiopharm. 2014 Mar;29(2):83-6. doi: 10.1089/cbr.2013.1568. Epub 2014 Jan 2. Cancer Biother Radiopharm. 2014. PMID: 24383763 Free PMC article.
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H, Wang J, Yuan YC, Frankel P, Li S, Ashing-Giwa KT, Sun G, Wang Y, Smith R, Robinson K, Ren X, Wang SE. Wu X, et al. Among authors: frankel p. J Transl Med. 2012 Mar 8;10:42. doi: 10.1186/1479-5876-10-42. J Transl Med. 2012. PMID: 22400902 Free PMC article.
269 results